Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Sprache: | |
| Veröffentlicht: |
Zenodo
2025
|
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.5281/zenodo.17689280 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Inhaltsangabe:
- Bevacizumab is associated with neurotoxic effects, predominantly Posterior Reversible Encephalopathy Syndrome (PRES), which usually resolves after discontinuation but may lead to ongoing sequelae.